The Hydroxylprolylproteome

描述（由申请人提供）：翻译后修饰在许多信号转导途径中发挥重要作用，我们尚未充分认识到这些修饰对细胞功能的影响程度。最近的研究强调了一种独特的修饰，丙基羟基化，在缺氧反应中的关键作用。在这个应用中，我们建议开发和使用新的捕获试剂来进行这种翻译后修饰。在后生动物中，缺氧反应的主要转录调控因子是缺氧诱导因子（Hypoxia Inducible Factor， HIF），它由一个和一个亚基组成。氧调节的HIF转换的关键事件是HIF的翻译后修饰-通过位点特异性脯氨酰羟基化，这允许von Hippel Lindau （VHL）肿瘤抑制蛋白识别，这是E3泛素连接酶复合物的一个组成部分，选择性地靶向羟基化的HIF-进行降解。这反过来又提出了一个更大的问题，即脯丙基羟基化是否在缺氧反应中发挥更广泛的作用。解决这个问题的一个主要限制是缺乏合适的试剂，可以专门识别脯丙基羟基化蛋白。我们建议开发新的羟脯氨酸捕获试剂，使用VHL作为引入位点定向突变的支架。这些突变将保留VHL的羟脯氨酸结合袋，目的是将反应性扩展到其他含有羟脯氨酸的蛋白质。基于vhl的羟基脯氨酸捕获试剂将用于免疫沉淀蛋白质，并通过质谱法获得它们的身份和脯氨酸羟基化位点。采用细胞培养和小鼠组织提取物的研究将用来表征这些脯氨酸羟基化事件的重要性。将开发用于高通量评估脯氨酰羟基化变化的平台。我们的合作者Stephen Master博士将专注于这些高通量研究和质谱分析。这些研究将挑战当前的范式，即脯氨酰羟基化在缺氧反应中的作用仅限于HIF。此外，它们将为评估羟基蛋白质组的动态变化提供基础，考虑到缺氧在包括心肌梗死、脑血管疾病和癌症在内的疾病中的作用，这具有相当重要的意义。

DESCRIPTION (provided by applicant): Posttranslational modifications play important roles in many signal transduction pathways, and we have yet to realize the full extent to which these modifications impact on cell function. Recent studies have highlighted a key role for a distinctive modification, prolyl hydroxylation, in the hypoxic response. In this application, we propose to develop and employ novel capture reagents for this posttranslational modification. The master transcriptional regulator of the hypoxic response in metazoans is Hypoxia Inducible Factor (HIF), which consists of an and a subunit. The key event in oxygen-regulated HIF turnover is posttranslational modification of HIF- by site-specific prolyl hydroxylation, which allows recognition by the von Hippel Lindau (VHL) tumor suppressor protein, a component of an E3 ubiquitin ligase complex that selectively targets hydroxylated HIF- for degradation. This, in turn, raises the larger question of whether prolyl hydroxylation may play a broader role in the hypoxic response. A major limitation to addressing this question is the lack of suitable reagents that can specifically recognize prolyl hydroxylated proteins. We propose developing novel hydroxylprolyl capture reagents using VHL as a scaffold for introducing site- directed mutations. These mutations will preserve the hydroxylprolyl binding pocket of VHL with the intention of extending reactivity to other hydroxylprolyl-containing proteins. The VHL-based hydroxylprolyl capture reagents will be employed to immunoprecipitate proteins, and their identity and sites of prolyl hydroxylation will be obtained by mass spectrometry. Studies employing cell culture and mouse tissue extracts will be employed to characterize the significance of these prolyl hydroxylation events. Platforms for assessing changes in prolyl hydroxylation in a high throughput manner will be developed. Our collaborator, Dr. Stephen Master, will focus on these high throughput studies and the mass spectrometry analyses. These studies will challenge the current paradigm that the role of prolyl hydroxylation in hypoxic responses is limited to HIF. Moreover, they will provide the basis for assessing dynamic changes in the hydroxylproteome, which is of considerable significance given the role of hypoxia in diseases that include myocardial infarction, cerebrovascular disease, and cancer.